Distinguishing the progression of an endometrioma: Benign or malignant?


BAŞTU E., Onder S. , Demiral I., Ozsurmeli M. , Keskin G., TAKMAZ Ö., ...Daha Fazla

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.230, ss.79-84, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 230
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.ejogrb.2018.09.026
  • Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Sayfa Sayıları: ss.79-84

Özet

Objective: To elucidate the immunohistochemical (IHC) differences of endometrioma tissues that may have the potential to progress to ovarian clear cell carcinoma (OCCC) by using KRAS, HNF1 beta, PIK3CA, PPP2R1A, and ARID1A as biomarkers.